Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Radiat Res. 2010 Oct;174(4):446-58. doi: 10.1667/RR2105.1.
To examine the possibility of using fractionated radiation in a unique way with molecular targeted therapy, gene expression profiles of prostate carcinoma cells treated with 10 Gy radiation administered either as a single dose or as fractions of 2 Gy × 5 and 1 Gy × 10 were examined by microarray analysis. Compared to the single dose, the fractionated irradiation resulted in significant increases in differentially expressed genes in both cell lines, with more robust changes in PC3 cells than in DU145 cells. The differentially expressed genes (>twofold change; P < 0.05) were clustered and their ontological annotations evaluated. In PC3 cells genes regulating immune and stress response, cell cycle and apoptosis were significantly up-regulated by multifractionated radiation compared to single-dose radiation. Ingenuity Pathway Analysis (IPA) of the differentially expressed genes revealed that immune response and cardiovascular genes were in the top functional category in PC3 cells and cell-to-cell signaling in DU145 cells. RT-PCR analysis showed that a flexure point for gene expression occurred at the 6th-8th fraction and AKT inhibitor perifosine produced enhanced cell killing after 1 Gy × 8 fractionated radiation in PC3 and DU145 cells compared to single dose. This study suggests that fractionated radiation may be a uniquely exploitable, non-oncogene-addiction stress pathway for molecular therapeutic targeting.
为了研究在分子靶向治疗中以独特的方式使用分次照射的可能性,通过微阵列分析检查了用 10 Gy 单次照射或 2 Gy×5 和 1 Gy×10 分次照射处理的前列腺癌细胞的基因表达谱。与单次照射相比,两种细胞系的差异表达基因均明显增加,PC3 细胞的变化比 DU145 细胞更为显著。差异表达基因(>两倍变化;P<0.05)进行聚类并评估其本体论注释。与单次照射相比,多分次照射可使 PC3 细胞中调节免疫和应激反应、细胞周期和凋亡的基因显著上调。差异表达基因的 IPA 分析显示,在 PC3 细胞中,免疫反应和心血管基因是功能分类的前 2 位,而在 DU145 细胞中,细胞间信号是功能分类的前 2 位。RT-PCR 分析显示,在第 6-8 次分次照射时出现了基因表达的拐点,与单次照射相比,在 PC3 和 DU145 细胞中,1 Gy×8 分次照射后 AKT 抑制剂培非司亭可增强细胞杀伤作用。本研究表明,分次照射可能是一种可独特利用的、非癌基因成瘾应激途径,可用于分子治疗靶向。